146 related articles for article (PubMed ID: 27512836)
1. Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk.
Estrada-Florez AP; Bohórquez ME; Sahasrabudhe R; Prieto R; Lott P; Duque CS; Donado J; Mateus G; Bolaños F; Vélez A; Echeverry M; Carvajal-Carmona LG
Medicine (Baltimore); 2016 Aug; 95(32):e4148. PubMed ID: 27512836
[TBL] [Abstract][Full Text] [Related]
2. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
4. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
[TBL] [Abstract][Full Text] [Related]
5. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24.
Jones AM; Howarth KM; Martin L; Gorman M; Mihai R; Moss L; Auton A; Lemon C; Mehanna H; Mohan H; Clarke SE; Wadsley J; Macias E; Coatesworth A; Beasley M; Roques T; Martin C; Ryan P; Gerrard G; Power D; Bremmer C; ; Tomlinson I; Carvajal-Carmona LG
J Med Genet; 2012 Mar; 49(3):158-63. PubMed ID: 22282540
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variant on 14q13.3 contributes to thyroid cancer susceptibility: evidence based on 12 studies.
Zheng J; Li C; Wang C; Ai Z
Mol Genet Genomics; 2015 Jun; 290(3):1125-33. PubMed ID: 25552255
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
[TBL] [Abstract][Full Text] [Related]
9. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population.
Rogounovitch TI; Bychkov A; Takahashi M; Mitsutake N; Nakashima M; Nikitski AV; Hayashi T; Hirokawa M; Ishigaki K; Shigematsu K; Bogdanova T; Matsuse M; Nishihara E; Minami S; Yamanouchi K; Ito M; Kawaguchi T; Kondo H; Takamura N; Ito Y; Miyauchi A; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2015 Mar; 25(3):333-40. PubMed ID: 25562676
[TBL] [Abstract][Full Text] [Related]
10. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
11. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
12. Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.
Świerniak M; Wójcicka A; Czetwertyńska M; Długosińska J; Stachlewska E; Gierlikowski W; Kot A; Górnicka B; Koperski Ł; Bogdańska M; Wiechno W; Jażdżewski K
Clin Cancer Res; 2016 Mar; 22(5):1111-9. PubMed ID: 26490305
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
Jendrzejewski J; Liyanarachchi S; Eiterman A; Thomas A; He H; Nagy R; Senter L; Sworczak K; de la Chapelle A
Int J Cancer; 2019 Feb; 144(3):503-512. PubMed ID: 30350351
[TBL] [Abstract][Full Text] [Related]
14. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
15. The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.
Sahasrabudhe R; Estrada A; Lott P; Martin L; Polanco Echeverry G; Velez A; Neta G; Takahasi M; Saenko V; Mitsutake N; ; Jaeguer E; Duque CS; Rios A; Bohorquez M; Prieto R; Criollo A; Echeverry M; Tomlinson I; ; ; Carmona LG
Endocr Relat Cancer; 2015 Oct; 22(5):841-9. PubMed ID: 26290501
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variants in the 8q24 region and risk of papillary thyroid cancer.
Neta G; Yu CL; Brenner A; Gu F; Hutchinson A; Pfeiffer R; Sturgis EM; Xu L; Linet MS; Alexander BH; Chanock S; Sigurdson AJ
Laryngoscope; 2012 May; 122(5):1040-2. PubMed ID: 22275265
[TBL] [Abstract][Full Text] [Related]
17. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
[TBL] [Abstract][Full Text] [Related]
18. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
[TBL] [Abstract][Full Text] [Related]
19. Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.
Gao Y; Chen F; Niu S; Lin S; Li S
Medicine (Baltimore); 2015 Sep; 94(36):e1246. PubMed ID: 26356687
[TBL] [Abstract][Full Text] [Related]
20. Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
Ai L; Liu X; Yao Y; Yu Y; Sun H; Yu Q
Endocrine; 2014 Nov; 47(2):428-34. PubMed ID: 24723258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
